Asian Development Bank provides $3 mn grant to India to combat COVID-19 pandemic
The grant will be used to procure thermal scanners and essential commodities to strengthen India's COVID-19 response, said the funding agency
New Delhi: Multilateral funding agency ADB on Wednesday said it has approved $3 million (about Rs 22 crore) grant to India from its Asia Pacific Disaster Response Fund to further support the government's emergency response to COVID-19 pandemic.
The grant, which is financed by the Japanese government, will be used to procure thermal scanners and essential commodities to strengthen the India's COVID-19 response, Asian Development Bank (ADB) said in a statement.
"The new grant complements ADB's ongoing support to the Government of India in strengthening its COVID-19 response. This support will enhance disease surveillance and help in early detection, contact tracing, and treatment. This will be further supplemented by other public health measures," it said.
On 28 April, ADB approved $1.5 billion COVID-19 Active Response and Expenditure Support (CARES) programme to support India in its immediate pandemic response efforts, including disease containment and prevention, as well as social protection measures for the poor and economically vulnerable, particularly women and disadvantaged groups.
The CARES programme is funded through the COVID-19 pandemic response option (CPRO) under ADB’s Counter-cyclical Support Facility.
CPRO was established as part of ADB's $ 20 billion expanded assistance for developing member countries’ pandemic response, which was announced on 13 April.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
UAE announces emergency use of COVID-19 vaccine that is still in its final testing, for healthcare workers
Chinese drug giant Sinopharm began the third phase of trials for a Covid-19 vaccine in the UAE in July, with Emirati officials saying the results have been positive.
Coronavirus LIVE Updates: The Serum Institute of India (SII) on Saturday said, "Once DCGI (Drugs Controller General of India) gives us permission to restart the trials in India, we will resume the trials."
COVID-19 tally rises to 54.88 lakh, Centre says India 'tops global figure in recoveries; Taj Mahal reopens after six months
With 93,356 COVID-19 patients being discharged in the last 24 hours, India recorded more than 90,000 recoveries for the third consecutive day on Monday